Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFD Technologies Regulatory News (FDP)

  • This share is currently suspended. It was suspended at a price of 2,450.00
  • There is currently no data for FDP

Trading Statement

25 Mar 2025 07:00

RNS Number : 9472B
FD Technologies PLC
25 March 2025
 

FD Technologies plc

Trading update for the 12 months ended 28 February 2025

25th March 2025

Strong FY25 performance with annual contract value ("ACV") at top end of guidance range and cash EBITDA above top end of consensus expectations

 

FY251

FY24

YoY (+/-)

£ million

Expected

Expected

ARR2

81.8

72.5

+13%

ACV3 added

18.0

13.5

+33%

Cash EBITDA4

(14.6)

(18.8)

NM

 

§

KX continued to execute well in the second half of the year, delivering FY bookings growth at the top end of our guidance range and ahead of consensus** expectations, with £18.0 million annual ACV (FY24: £13.5 million), +33 per cent YoY.

§

KX achieved a significant milestone, with annual recurring revenue exceeding $100 million* for the first time, after constant currency growth of 13 per cent to £81.8 million (FY24: £72.5 million), in line with the guidance range.

§

Cash EBITDA was ahead of guidance and above the top end of consensus expectations with a loss of £14.6 million (FY24: loss of £18.8 million).

§

Proven use cases are driving the adoption of KDB.AI, which facilitates real-time AI-powered research assistance, anomaly detection, predictive analytics in capital markets, and satellite imagery analysis and signal processing in aerospace and defence.

§

Market demand for time-series AI is growing as industries shift towards real-time, context-aware AI. KDB.AI's ability to seamlessly combine historical and real-time data with low-latency AI processing sets it apart as a category leader.

§

Following the divestment of MRP (retaining a 49 per cent associate investment in the resulting merged entity, PharosIQ) and First Derivative, we returned £120 million to shareholders and KX closed the year with £56 million net cash and no debt.

§

We enter FY26 with a strong and growing pipeline of expansion and new opportunities across capital markets, aerospace and defence, and industrial IoT. This gives us confidence at this early stage in the year that we can achieve FY26 ARR growth of at least 20%.

Seamus Keating, Group CEO of FD Technologies, commented:

"We made significant strategic and operational progress in FY25. With accelerating ARR growth and better-than-expected operating leverage, KX delivered a strong performance based on good ongoing execution. We restructured our business to focus solely on KX, returned £120 million of value to shareholders, and ensured that KX is well capitalised to execute its strategy for growth and profitability."

Ashok Reddy, CEO of KX, added:

"The strong bookings growth in the period demonstrates that our strategy is working and reflects the benefits of our investments to enhance our go-to-market operations and simplify adoption. We enter FY26 with a strong and growing pipeline of expansion and new opportunities across capital markets, aerospace and defence, and industrial IoT, and view the outlook for the year with confidence."

* £81.8 million ARR restated in US dollars was $103.1 million, using the US$/£ exchange rate of 1.26 on 28 February 2025.

** On 28 February 2025, the company-compiled analyst mean consensus estimates indicated £16.7 million in ACV added during the period (range £16.0-17.0 million), £82.8 million in ARR (range £81.2-84.5 million), and an £18.5 million Cash EBITDA loss (range of £16.3-20.1 million loss). The consensus included estimates from six analysts.

 

1 All figures are only for KX's continuing operations and exclude the divested First Derivative business.

2 Annual recurring revenue: the total value of recurring software revenue expected to be recognised over the next 12 months, on the final day of the reporting period.

3 Annual contract value: the sum of the value of each customer contract signed during the year divided by the number of years in each contract.

4 Earnings before interest, tax, depreciation and amortisation adjusted to exclude share-based payments, capitalised R&D, and exceptional items.

 

Contacts

 

FD Technologies plc

Seamus Keating, Chief Executive Officer

Ryan Preston, Chief Financial Officer

Derek Brown, SVP Investor Relations

 

www.fdtechnologies.com

investors@kx.com

Investec Bank plc - Nominated Adviser and Broker

Carlton Nelson

Virginia Bull

+44 (0)20 7597 5970

Goodbody - Euronext Growth Adviser and Broker

Don Harrington

Jason Molins

Tom Nicholson

+353 1 667 0420

 

J.P. Morgan Cazenove - Broker

James A. Kelly

Mose Adigun

+44 (0)20 3493 8000

 

FTI Consulting - Financial PR

Matt Dixon

Dwight Burden

Victoria Caton

+44 (0)20 3727 1000

fdtechnologies@fticonsulting.com

 

About KX

KX is on a mission to make AI a commercial reality for the many by addressing data challenges that impede deployment at scale. By simultaneously ingesting and analysing high volumes of historical and real-time data, KX's AI-ready analytical database enables organizations to unlock the full value of their data to accelerate innovation and make faster, more confident decisions.

 

KX is the world's most performant, cost-effective and energy-efficient analytical database, delivering advanced data algorithms, insights and analytics at unmatched scale and speed. KX is trusted by the world's top investment banks, Aerospace and Defence, high-tech manufacturing and health and life sciences organisations and operates across North America, Europe, and Asia Pacific.

 

For further information, please visit www.fdtechnologies.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBRGDXBDDDGUS
Date   Source Headline
7th Mar 20167:00 amRNSEnterprise Securities Market Notice
1st Mar 20164:14 pmRNSIssue of Equity
29th Jan 20169:46 amRNSTotal Voting Rights
25th Jan 20167:00 amRNSEnterprise Securities Market Notice
22nd Jan 20163:31 pmRNSDirector/PDMR Shareholding
19th Jan 20163:28 pmRNSIssue of Equity
19th Jan 201611:16 amRNSDirector's Shareholding
19th Jan 201610:39 amRNSHolding(s) in Company
15th Jan 20167:00 amRNSEnterprise Securities Market Notice
14th Jan 20167:00 amRNSMOU with Utilismart
13th Jan 20163:25 pmRNSHolding(s) in Company
12th Jan 20167:00 amRNSFD acquires QuantumKDB
31st Dec 20157:00 amRNSTotal Voting Rights
7th Dec 20157:00 amRNSEnterprise Securities Market Notice
3rd Dec 20155:00 pmRNSHolding(s) in Company
1st Dec 20154:49 pmRNSIssue of Equity from exercise of Share Options
11th Nov 20157:00 amRNSHalf Yearly Report
2nd Nov 20157:00 amRNSContract win with National Stock Exchange of India
19th Oct 20157:00 amRNSNotice of Results and Trading Update
30th Sep 20151:33 pmRNSTotal Voting Rights
23rd Sep 20154:46 pmRNSIssue of Equity
16th Sep 20153:07 pmRNSHolding(s) in Company
10th Sep 20157:00 amRNSFormation of FD Labs
28th Aug 20157:00 amRNSTotal Voting Rights
6th Aug 20157:00 amRNSEnterprise Securities Market Notice
3rd Aug 20157:00 amRNSAppointment of Non-Executive Director
31st Jul 201511:22 amRNSIssue of Equity
31st Jul 201511:19 amRNSTotal Voting Rights
21st Jul 20153:22 pmRNSDirector/PDMR Shareholding
7th Jul 20155:31 pmRNSIssue of Equity from exercise of Share Options
25th Jun 20152:02 pmRNSResult of AGM
12th Jun 20155:15 pmRNSDirector's Shareholding
2nd Jun 20157:00 amRNSPreliminary Results
29th May 20154:59 pmRNSTotal Voting Rights
11th May 20157:00 amRNSChange of Adviser and Notice of Results
8th Apr 20157:00 amRNSEnterprise Securities Market Notice
1st Apr 201511:09 amRNSTotal Voting Rights
1st Apr 20157:00 amRNSFD acquires Affinity Systems for up to GBP7.7m
27th Mar 20157:00 amRNSEnterprise Securities Market Notice
24th Mar 20157:01 amRNSDirectorate Change and Appointment
24th Mar 20157:00 amRNSFD acquires ActivateClients Limited
19th Mar 20157:00 amRNSEnterprise Securities Market Notice
13th Mar 20154:29 pmRNSIssue of Equity
4th Mar 20157:00 amRNSEnterprise Securities Market Notice
4th Mar 20157:00 amRNSEnterprise Securities Market Notice
3rd Mar 20152:00 pmRNSFirst Derivatives strengthens board of Directors
3rd Mar 201511:06 amRNSResult of General Meeting
27th Feb 201511:27 amRNSTotal Voting Rights
26th Feb 20157:01 amRNSFD acquires Prelytix for up to USD20million
23rd Feb 20157:00 amRNSEnterprise Securities Market Notice

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.